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[Abstract] The transmembrane proton gradient (pH) is the primary source of energy exploited by 12 
secondary active substrate/H+ antiporters to drive the electroneutral transport of substrates across the 13 
Escherichia coli (E. coli) inner membrane. Such electroneutral transport results in no net movement of 14 
charges across the membrane. The charge on the transported substrate and the stoichiometry of the 15 
exchange reaction, however, can result in an electrogenic reaction which is driven by both the pH 16 
and the electrical (∆) components of the proton electrochemical gradient, resulting in a net 17 
movement of electrical charges across the membrane. We have shown that the major facilitator 18 
superfamily transporter MdtM - a multidrug efflux protein from E. coli that functions physiologically in 19 
protection of bacterial cells against bile salts - imparts bile salt resistance to the bacterial cell by 20 
coupling the exchange of external protons (H+) to the efflux of bile salts from the cell interior via an 21 
electrogenic antiport reaction (Paul et al., 2014). This protocol describes, using fluorometry, how to 22 
detect electrogenic antiport activity of MdtM in inverted membrane vesicles of an antiporter-deficient 23 
strain of E. coli TO114 cells by measuring transmembrane ∆. The method exploits changes that 24 
occur in the intensity of the fluorescence signal (quenching and dequenching) of the probe Oxonol V 25 
in response to changes in membrane potential due to the MdtM-catalysed sodium cholate/H+ 26 
exchange reaction. The protocol can be adapted to detect activity of any secondary active antiporter 27 
that couples the electrogenic translocation of H+ across a biological membrane to that of its counter-28 
substrate, and may be used to unmask otherwise camouflaged transport activities and physiological 29 
roles. 30 
 31 
Materials and Reagents 32 
 33 
1. E. coli TO114 cells (gift of Prof. Hiroshi Kobayashi, Chiba University, Japan) 34 
2. E. coli BW25113 cells (National BioResource Project, Japan) 35 
3. Bis-(3-phenyl-5-oxoisoxazol-4-yl)pentamethine oxonol (Oxonol V) (Life Technologies, 36 
Molecular Probes®, catalog number: O-266) 37 
Note: In our original work we used Oxonol V supplied by Cambridge Bioscience Ltd. 38 
However, this product no longer appears in their catalogue. 39 
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4. Nigericin (Sigma-Aldrich, catalog number: N7143) 40 
5. Valinomycin (Sigma-Aldrich, catalog number: 94675) 41 
6. BisTris propane (BTP) (Sigma-Aldrich, catalog number: B6755) 42 
7. Phenylmethanesulfonyl fluoride (PMSF) (Sigma-Aldrich, catalog number: P7626) 43 
8. Deoxyribonuclease I (DNase) from bovine pancreas (Sigma-Aldrich, catalog number: DN25) 44 
9. Carbonyl cyanide 3-chlorophenylhydrazone (CCCP) (Sigma-Aldrich, catalog number: C2759) 45 
10. Sodium DL-lactate solution 50% aqueous (VWR International, catalogue number: 27927.298) 46 
11. Magnesium sulphate heptahydrate (MgSO4.7H2O) (Thermo Fisher Scientific, catalogue 47 
number: M/1000/60) 48 
12. Sodium cholate hydrate (Sigma-Aldrich, catalog number: C1254) 49 
13. Sodium D-gluconate (Sigma-Aldrich, catalog number: S2054) 50 
14. Potassium D-gluconate (Sigma-Aldrich, catalog number: G4500) 51 
15. Absolute ethanol (Thermo Fisher Scientific, catalogue number: E/0650DF/17) 52 
16. High purity (18 M) Millipore or AnalR water 53 
17. D-sorbitol (Sigma-Aldrich, catalog number: S1876) 54 
18. Sucrose (Sigma-Aldrich, catalog number: 84097) 55 
19. DL-dithiothreitol (Sigma-Aldrich, catalog number: 43815) 56 
20. TRIZMA base (Sigma-Aldrich, catalog number: T1503) 57 
21. Sulphuric acid (Sigma-Aldrich, catalog number: 320501) 58 
22. Tris/sorbitol/dithiothreitol/sucrose (TSDS) buffer (see Recipes) 59 
23.  Transport assay buffer (see Recipes) 60 
24.  2 M sodium D-gluconate stock solution (see Recipes) 61 
25.  2 M potassium D-gluconate stock solution (see Recipes) 62 
 63 
Equipment 64 
 65 
1. Temperature-controlled shaking incubator for bacterial growth 66 
2. Large ice bucket 67 
3. Refrigerated, large capacity centrifuge and rotor for harvesting bacterial cells 68 
4. 1,000 ml or 500 ml centrifuge pots and lids 69 
5. Benchtop vortexer 70 
6. 100 ml conical flask 71 
7. 100 ml beaker and stir bar to fit 72 
8. Magnetic stirrer 73 
9. 25 ml disposable plastic pipettes 74 
10. Selection of single channel pipettes (1,000 µl, 100 µl, 20 µl, 10 µl) 75 
11. Pipette tips for above 76 
12. Refrigerated centrifuge and rotor capable of spinning ~50 ml tubes at 18k x g. 77 
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13. Refrigerated ultracentrifuge, rotor and polycarbonate ultracentrifuge tubes capable of handling 78 
~30 - 50 ml volumes 79 
14. French Press (Thermo Electron Corp, catalogue number: FA-078) 80 
15. Standard pressure cell (40 kpsi; 35 ml capacity) (Thermo Electron Corp, catalogue number: 81 
FA-031) 82 
16. 50 ml syringes (for filtering solutions) 83 
17. 0.22 µm sterile filters to fit 50 ml syringe 84 
18. 1 L and 500 ml Duran bottles with lids 85 
19. 1.5 ml Eppendorf tubes 86 
20. Medical wipes (Kimwipes®) 87 
21. Parafilm 88 
22. UV/vis spectrophotometer and 10 mm pathlength quartz cuvette 89 
23. 10 x 4 mm, 1,400 µl volume quartz cuvette for fluorescence spectroscopy (Hellma, catalog 90 
number: 104F-QG) 91 
24. Small magnetic stir bar to fit inside quartz cuvette 92 
25. Fluorometer e.g. Fluoromax-4 (Horiba) capable of performing time-based acquisition 93 
measurements and fitted with a temperature controlled cuvette holder and stirrer 94 
26. Source of compressed air (either aerosol can or fixed supply) for drying cuvette 95 
 96 
Procedure 97 
 98 
A. Harvesting bacterial cultures and preparation of inverted membrane vesicles 99 
1. Due to typically low levels of endogenous transporter expression, this method necessitates 100 
that the transporter of interest be overexpressed from a multicopy plasmid. Although the 101 
protocol described here pertains to measurement of electrogenic bile salt (sodium cholate) 102 
transport by a specific membrane transporter protein (MdtM), it can be easily adapted for 103 
measurement of the electrogenicity of transport by other secondary active antiporters. We 104 
have therefore omitted description of the bacterial growth and protein overexpression 105 
conditions (as these are usually different for every membrane protein), and begin the 106 
procedure from the point of harvesting of 1 L cultures of bacterial cells enriched with plasmid-107 
encoded antiporter. Typically, a 1 L culture of bacterial cells will provide sufficient material for 108 
these experiments. 109 
2. Transfer the E. coli TO114 cells that contain overexpressed transporter into 500 ml or 1,000 110 
ml capacity centrifuge pots that have been pre-chilled on ice for at least 15 mins.  Pre-cool the 111 
centrifuge to 4 C and harvest cells by centrifugation at 5,000 x g for 20 min.  112 
3. Decant the supernatant and wash the pelleted cells by resuspending (either by gentle 113 
vortexing using a benchtop vortexer or by gentle aspiration using a 25 ml sterile plastic 114 
pipette) in chilled (4 C) TSDS buffer. Use 30 ml of TSDS buffer for each one litre of cell 115 
culture that was pelleted. Maintain the cells on ice during this procedure. Harvest the washed 116 
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cells by centrifugation as described in step A1 (above) and repeat the washing procedure. 117 
Resuspend the resultant cell pellet in 30 ml of chilled TSDS buffer containing 2 mM PMSF 118 
(Which should be made up as a 100 mM stock in ethanol and stored at -20 C; ensure the 119 
solution is thawed thoroughly and vortexed vigorously before use.) and 5 µM DNase and 120 
maintain the mixture on ice. 121 
4. Decant the resuspended cells into a 100 ml beaker containing a stir bar, place on a magnetic 122 
stirrer and stir in a cold room at 4 C or on ice for 20 min. 123 
5. Generate inverted membrane vesicles by a single passage of the resuspended cell mixture 124 
through a French pressure cell at a minimum of 4,000 psi. If the pressure is too low, inverted 125 
vesicles will not be formed. The pressure cell should be chilled on ice for ~30 min prior to use. 126 
The vesicle mixture should be collected in a 100 ml conical flask kept on ice. 127 
6. Decant the mixture into a pre-chilled ~50 ml centrifuge tube and remove any unbroken cells 128 
and cell debris by centrifugation at 18,000 x g for 10 min at 4 C. Carefully decant the 129 
supernatant containing the cell membrane vesicles into a pre-chilled 30-50 ml volume 130 
polycarbonate ultracentrifuge tube on ice. 131 
7. Harvest the inverted vesicles by ultracentrifugation at 100,000 x g for 1 h at 4 C. Carefully 132 
decant the supernatant and retain the pellet. Place the ultracentrifuge tube containing the 133 
pelleted vesicles on ice. 134 
8. Thoroughly resuspend the inverted vesicle pellet in 1 ml of ice-cold TSDS buffer by gentle 135 
aspiration using a 1,000 µl pipette. Transfer the resuspended vesicles to a pre-chilled 1.5 ml 136 
Eppendorf tube on ice for use in the transport assay. In our experience, vesicles stored on ice 137 
are stable for several hours. 138 
9. Quantify the total membrane protein content of the inverted vesicles by UV absorbance 139 
spectroscopy at 280 nm. Blank the spectrophotometer using a 10 mm pathlength quartz 140 
cuvette containing 1,000 µl of TSDS buffer. The buffer should be at room temperature to 141 
prevent frosting of the cuvette faces. Clean the faces of the cuvette using a fresh paper wipe 142 
prior to measurement. Once the spectrophotometer is blanked, remove 5 µl of buffer from the 143 
cuvette using a 10 µl pipette and replace with 5 µl of vesicles. Cover the opening of the 144 
cuvette with a square of Parafilm and invert the cuvette a few times to ensure a homogeneous 145 
distribution of vesicles. Record the absorbance of the vesicle mixture at 280 nm and calculate 146 
the total membrane protein concentration assuming that an A280 of 1.0 is equivalent to a 147 
protein concentration of 1.0 mg/ml. Remember to multiply the 280 nm absorbance value you 148 
obtain by a factor of 200 to calculate the concentration of the undiluted vesicle mixture in 149 
mg/ml. 150 
 151 
B. Measurement of electrogenic transport  152 
1. In this section we describe the set-up parameters for a Fluoromax-4 fluorometer. These 153 
parameters, however, can form the basis for the set-up of other fluorometers. Once the 154 
instrument is switched on and the software booted up, set the temperature of the cuvette 155 
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holder to 25 C. Open the instrument software and select for time-based data acquisition with 156 
excitation and emission wavelengths of 599 nm and 634 nm, respectively. Set the excitation 157 
and emission slit widths to 10 nm and 20 nm, respectively. 158 
2. Add an aliquot of inverted vesicles (which should be maintained on ice in TSDS buffer) to 159 
room temperature transport assay buffer containing the Oxonol V probe in a 10 mm x 4 mm 160 
quartz cuvette to a final concentration of 0.5 mg/ml membrane protein in a total volume of 161 
1,500 µl.  The longest pathlength of the cuvette should face the excitation light source. Place 162 
a small magnetic flea into the cuvette and stir the contents gently. Allow the vesicles and 163 
assay buffer to equilibrate for ~200 sec. 164 
3. Start recording the fluorescence emission. 165 
4. After approximately 50 sec, add 15 µl of 200 mM stock solution of sodium DL-lactate to the 166 
cuvette contents to give a final sodium DL-lactate concentration of ~2.0 mM. Addition of 167 
lactate initiates respiration-dependent generation of ∆ that causes a dequench of the Oxonol 168 
V fluorescence signal (see Figure 1). 169 
5. If the fluorescence signal does not quench, or enhances, the vesicles have either not 170 
maintained integrity or are not inverted and their preparation needs to be repeated. 171 
6. Following the establishment of ∆, monitor the Oxonol V fluorescence dequench for a further 172 
~150 sec until it stabilises. Initiate MdtM-mediated antiport by adding substrate (in this case 173 
the bile salt sodium cholate) to the inverted vesicle mixture. We added 12.5 µl of 250 mM 174 
stock solution made up in high purity water to give a final concentration of sodium cholate in 175 
the cuvette of ~2.0 mM. For other substrates we suggest testing a range varying from 1 mM 176 
to 100 mM to establish the concentration that gives the best dequench signal. If the transport 177 
reaction is electrogenic there should be an immediate dequench (enhancement) of the 178 
Oxonol V fluorescence emission signal as the established membrane potential, , is 179 
consumed by the transport reaction (see Figure 1a). 180 
7. Record the fluorescence dequench signal for ~60 s to allow the antiport reaction to achieve a 181 
steady state (as observed by a plateauing of the fluorescence signal). Addition of the 182 
protonophore CCCP to a final concentration of ~100 µM (1.6 µl of a 100 mM stock made up in 183 
ethanol) in the assay mixture should be performed to abolish transport by collapsing both the 184 
membrane potential and pH. Addition of CCCP should result in a further dequench of the 185 
fluorescence signal (see Figure 1a). Record the fluorescence signal for a further ~40 sec then 186 
terminate the acquisition and save the electronic data. 187 
8. Decant the cuvette contents into a suitable waste container and wash the cuvette thoroughly 188 
with ethanol then high-purity water. Dry the cuvette carefully with compressed air. 189 
9. As a further control, and to provide evidence that the inverted vesicles retain integrity and are 190 
therefore able to maintain an electrochemical potential across the membrane during the 191 
assay lifetime, the fluorescence response of Oxonol V upon addition of the ionophore 192 
nigericin (which at low concentrations selectively consumes pH in the presence of potassium 193 
ions via electroneutral K+/H+ exchange) in place of substrate should be measured. For this 194 
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experiment, inverted vesicles of TO114 cells containing the transporter of interest are 195 
incubated in assay buffer that contains 50 mM potassium D-gluconate. After addition of 196 
sodium DL-lactate to initiate respiration as described in step B3 above, 1.5 µl of 1 mM 197 
nigericin stock solution made up in ethanol (to give a final concentration of ~1 µM) is added to 198 
the cuvette. Concentrations of nigericin > 1 µM must be avoided to prevent electrogenic 199 
exchange that can occur under conditions of high nigericin concentrations and abolish both 200 
components of the electrochemical gradient. Record the fluorescence dequench signal for a 201 
further ~60 s then add the ionophore valinomycin (to selectively abolish ) to a final 202 
concentration of ~5 μM by adding ~1.6 μl of 5 mM stock made up in ethanol (see Figure 1d).  203 
Record data for a further 40 sec prior to termination of the acquisition. 204 
 205 
Representative data 206 
 207 
 208 
Figure 1. Representative data illustrating typical changes in the fluorescence signal of the 209 
-sensitive fluorophore Oxonol V in response to MdtM-catalysed electrogenic transport 210 
in inverted membrane vesicles. Addition of lactate to energise vesicles results in 211 
generation of a respiratory , as evidenced by a rapid quench of the Oxonol V 212 
fluorescence signal. (a) Addition of 2.5 mM cholate to inverted vesicles generated from TO114 213 
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cells enriched with wild-type MdtM results in a partial depolarization of , represented as a 214 
dequenching of the Oxonol V fluorescence, as the  was consumed by the MdtM-mediated bile 215 
salt/H+ transport reaction. (b) Addition of cholate to negative control vesicles generated from 216 
TO114 cells enriched with dysfunctional MdtM D22A results in a small but perceptible dequench 217 
arising from residual electrogenic Na+/H+ antiport activity of the mutant. (c) Positive control assay 218 
in which Na+ ions are added to inverted vesicles that contain a full complement of electrogenic 219 
antiporters in order to measure electrogenic Na+/H+ activity of NhaA transporter. (d) Response of 220 
Oxonol V fluorescence to addition of the nigericin. In the presence of K+ ions, this ionophore 221 
selectively dissipates pH and converts it into , resulting in a further quench of the 222 
fluorescence signal. Valinomycin collapses the . In assays (a,b and c), addition of the 223 
protonophore CCCP at the time indicated resulted in almost complete dissipation of . 224 
 225 
Notes 226 
 227 
a. Resuspended inverted vesicles from step A8 can be transferred to tubes in aliquots of 228 
25-100 µl, snap-frozen in liquid nitrogen and stored at -80 C for subsequent use. 229 
Vesicles frozen in this way will retain their integrity for several months. However, if frozen 230 
vesicle stocks are used for the subsequent transport measurements, the vesicles must 231 
be thawed very slowly on ice prior to use to prevent their fracture. 232 
b. To ensure the suitability of the experimental conditions for detection of electrogenic 233 
antiport, a positive control should first be performed using inverted vesicles produced 234 
from E. coli cells e.g. strain BW25113 that contain a full complement of electrogenic 235 
antiporters. This control experiment should be performed by following the protocol below 236 
except that the transport assay buffer pH should be adjusted to pH 8.5 with H2SO4, and 237 
sodium gluconate (to a final concentration in the cuvette of ~100 mM by adding 80 µl of a 238 
2 M stock of sodium gluconate) should be added in place of sodium cholate to 239 
specifically enable detection of electrogenic Na+/H+ exchange catalysed by the NhaA 240 
transporter (Figure 1c). 241 
c. To ensure reproducibility, the assays should be performed in triplicate on at least two 242 
separate preparations of inverted vesicles. 243 
d. As with all assays that rely on detection of fluorescence, robust controls must be in place 244 
to ensure that any detected transport activity can be attributed unambiguously to the 245 
protein of interest. In our experiments, we used inverted vesicles that overexpressed 246 
MdtM D22A, a dysfunctional point mutant of MdtM, as a negative control (see Figure 1b). 247 
e. If the method is to be used for detection of metal ion/H+ antiport activity, the use of 248 
inverted vesicles generated from the antiporter-deficient TO114 strain of E. coli is 249 
important because at least four other transporters (NhaA, NhaB, ChaA and MdfA) 250 
present in the bacterium can catalyse a monovalent metal cation/H+ exchange. 251 
8 
 
f. Because chloride ions can depolarise the membrane potential, all buffer systems must 252 
be maintained as chloride-free. Therefore, pH of buffers should be adjusted using H2SO4 253 
instead of HCl. 254 
g. Finally, if this protocol is used for comparison of antiport activities of wild type and mutant 255 
transporters, the amount of target protein present in the inverted vesicle membranes 256 
must be quantified (usually by immunodetection methods) to ensure that any measured 257 
differences in H+ uptake are due solely to differences in the activity of the transporters 258 
and not to differences in expression levels. 259 
  260 
Recipes 261 
 262 
1. Tris/sorbitol/dithiothreitol/sucrose (TSDS) buffer (1 L)  263 
Consisting of 10 mM Tris (pH 7.5), 280 mM sorbitol, 0.5 mM dithiothreitol and 250 mM 264 
sucrose 265 
1 M Tris (pH 7.5) 10 ml 266 
1 M sorbitol 280 ml 267 
1 M sucrose 250 ml 268 
Make up to 999.5 ml with high purity water then check pH and adjust if necessary with H2SO4 269 
Sterile filter and store at 4 C  270 
Add 0.5 ml dithiothreitol from frozen 1 M stocks immediately before use 271 
2. Transport assay buffer (100 ml)  272 
Consisting of 10 mM BisTris propane (pH 7.2) (or pH 8.5 for the initial control experiment), 5 273 
mM MgSO4, 5 μM Oxonol V 274 
100 mM BisTris propane (pH 7.2 or pH 8.5) 10 ml 275 
2 M MgSO4 0.25 ml 276 
1 mM Oxonol V (made up in ethanol) 0.5 ml 277 
Make up to 100 ml with high purity water then sterile filter.  278 
For control experiments that use nigericin, potassium D-gluconate (2.5 ml of 2 M stock) to a 279 
final concentration of 50 mM should be added to the assay buffer.  280 
Oxonol V is light sensitive so both the transport assay buffer and Oxonol V stocks should be 281 
stored either in amber bottles or in a container protected from light. 282 
3. 2 M sodium D-gluconate stock solution (10 ml) 283 
4.36 g made up to 10 ml with high purity water 284 
Sterile filter and store at 4 C 285 
4. 2 M potassium D-gluconate stock solution (10 ml) 286 
4.68 g made up to 10 ml with high purity water 287 
Sterile filter and store at 4 C 288 
 289 
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